Q

Quince Therapeutics
D

QNCX

31.750
USD
-3.58
(-10.13%)
مغلق
حجم التداول
0
الربح لكل سهم
-8
العائد الربحي
-
P/E
-0
حجم السوق
32,291,750
المقالات
المزيد

العنوان: Quince Therapeutics Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.